BMJ - Head To Head: Should I publish in an open access journal? (6) Researchers' perspectives on open access (2)

20 April, 2019

Indeed. Would be great to investigate where “big pharma” research results are published. One probably should not forget that a lot of what “big pharma” publishes is the positive outcome of their research rather than the outcome of all the research they do.

Best regards.

Najeeb Al-Shorbaji, PhD, FIAHSI

President of the eHealth Development Association of Jordan,

Independent Consultant in Knowledge Management and eHealth,

e-Marefa Advisor

P.O. Box 542006

Amman 11937

Jordan

Mobile +962 799391604

Tel. +962 (6) 5240273

Skype: Najeeb.al.Shorbaji

Twitter: shorbajin

LinkedIn: https://www.linkedin.com/in/najeeb-al-shorbaji-7a817415/

HIFA Profile: Najeeb Al-Shorbaji recently retired from the World Health Organization (WHO), where he has worked since 1988 in different capacities. He was most recently Director of the Knowledge, Ethics and Research Department at WHO headquarters, Geneva. Previously he was Coordinator for Knowledge Management and Sharing in EMRO (Eastern Mediterranean Regional Office), Egypt. He is a member of a number of national and international professional societies and associations specialised in information management and health informatics. He has authored over 100 research papers and articles presented in various conferences and published in professional journals. He is a member of the HIFA Steering Group.

http://www.hifa.org/people/steering-group

http://www.hifa.org/support/members/najeeb

Email: shorbajin AT gmail.com